AAAAAA
Results: 1-25/33
Authors:
CAMERON EH
LIPSHULTZ SE
TARBELL NJ
MAUCH PM
Citation: Eh. Cameron et al., CARDIOVASCULAR-DISEASE IN LONG-TERM SURVIVORS OF PEDIATRIC HODGKINS-DISEASE, Progress in pediatric cardiology, 8(3), 1998, pp. 139-144
Authors:
VANOS R
ROBINSON S
SHERIDAN TM
MAUCH PM
Citation: R. Vanos et al., RESPIRATORY BURST OF NEUTROPHILS IS NOT REQUIRED FOR STEM-CELL MOBILIZATION, Experimental hematology, 26(8), 1998, pp. 27-27
Authors:
SHERIDAN TM
ROBINSON S
MAUCH PM
VANOS R
Citation: Tm. Sheridan et al., POTENTIAL IMMUNOGENICITY OF LY5 ANTIGENS IN BONE-MARROW TRANSPLANTATION, Experimental hematology, 26(8), 1998, pp. 264-264
Authors:
VANOS R
AVRAHAM H
BANU N
MAUCH PM
WHATER J
YANG YM
DU B
Citation: R. Vanos et al., RECOMBINANT ADENOASSOCIATED VIRUS-BASED VECTORS ARE UNABLE TO PERMANENTLY TRANSDUCE PRIMITIVE HEMATOPOIETIC STEM-CELLS, Experimental hematology, 26(8), 1998, pp. 284-284
Authors:
SMITH D
SHAFFER K
KIRN D
CANELLOS GP
MAUCH PM
SHULMAN LN
Citation: D. Smith et al., MEDIASTINAL LARGE-CELL LYMPHOMA - PROGNOSTIC-SIGNIFICANCE OF CT FINDINGS AT PRESENTATION AND AFTER TREATMENT, Oncology, 55(4), 1998, pp. 284-288
Authors:
VANOS R
ROBINSON S
SHERIDAN T
MISLOW JMK
DAWES D
MAUCH PM
Citation: R. Vanos et al., GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCES BONE-MARROW STEM-CELL DAMAGE CAUSED BY REPEATED ADMINISTRATION OF CYTOTOXIC AGENTS, Blood, 92(6), 1998, pp. 1950-1956
Authors:
VANOS R
DEWITTE T
DILLINGH JH
MAUCH PM
DOWN JD
Citation: R. Vanos et al., INCREASED REJECTION OF MURINE ALLOGENEIC BONE-MARROW IN PRESENSITIZEDRECIPIENTS, Leukemia, 11(7), 1997, pp. 1045-1048
Authors:
BODIS S
KRAUS MD
PINKUS G
SILVER B
KADIN ME
CANELLOS GP
SHULMAN LN
TARBELL NJ
MAUCH PM
Citation: S. Bodis et al., CLINICAL PRESENTATION AND OUTCOME IN LYMPHOCYTE-PREDOMINANT HODGKINS-DISEASE, Journal of clinical oncology, 15(9), 1997, pp. 3060-3066
Authors:
MAUCH PM
Citation: Pm. Mauch, OUTCOMES ANALYSIS, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 101-101
Authors:
MAUCH PM
YAHALOM J
Citation: Pm. Mauch et J. Yahalom, HODGKINS-DISEASE .1. EPIDEMIOLOGY, PATHOLOGY, STAGING, AND MANAGEMENTOF EARLY-STAGE DISEASE, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 123-123
Authors:
YAHALOM J
MAUCH PM
Citation: J. Yahalom et Pm. Mauch, HODGKINS-DISEASE .2. MANAGEMENT OF ADVANCED-STAGE DISEASE, RELAPSED DISEASE AND LONG-TERM COMPLICATIONS OF TREATMENT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 128-128
Authors:
HUGHESDAVIES L
TARBELL NJ
COLEMAN CN
SILVER B
SHULMAN LN
LINGGOOD R
CANELLOS GP
MAUCH PM
Citation: L. Hughesdavies et al., STAGE IA-IIB HODGKINS-DISEASE - MANAGEMENT AND OUTCOME OF EXTENSIVE THORACIC INVOLVEMENT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 361-369
Authors:
VANOS R
ROBINSON S
SHERIDAN TM
MAUCH PM
Citation: R. Vanos et al., POSSIBLE MECHANISMS FOR ADVERSE-EFFECTS ON PRIMITIVE STEM-CELLS WHEN G-CSF IS COMBINED WITH VARIOUS CHEMOTHERAPEUTIC DRUGS, Experimental hematology, 25(8), 1997, pp. 218-218
Authors:
VANOS R
LAMONT G
WITSELL A
MAUCH PM
Citation: R. Vanos et al., RADIOPROTECTION OF BONE-MARROW STEM-CELL SUBSETS BY INTERLEUKIN-1 ANDKIT-LIGAND - IMPLICATIONS FOR CFU-S AS THE RESPONSIBLE TARGET-CELL POPULATION, Experimental hematology, 25(3), 1997, pp. 205-210
Authors:
VANOS R
ROBINSON S
SHERIDAN TM
MAUCH PM
Citation: R. Vanos et al., EVIDENCE FOR ADVERSE-EFFECTS OF G-CSF THROUGH INCREASED PROLIFERATIONAT THE EXPENSE OF SELF-RENEWAL WHEN COMBINED WITH STEM-CELL DAMAGING CYTOTOXIC AGENTS, Blood, 90(10), 1997, pp. 409-409
Authors:
VANOS R
DAWES D
MISLOW JMK
WITSELL A
MAUCH PM
Citation: R. Vanos et al., HOST CONDITIONING WITH 5-FLUOROURACIL AND KIT-LIGAND TO PROVIDE FOR LONG-TERM BONE-MARROW ENGRAFTMENT, Blood, 89(7), 1997, pp. 2376-2383
Authors:
MAUCH PM
Citation: Pm. Mauch, MANAGEMENT OF EARLY-STAGE HODGKINS-DISEASE - THE ROLE OF RADIATION-THERAPY AND OR CHEMOTHERAPY/, Bailliere's clinical haematology, 9(3), 1996, pp. 531-541
Authors:
MAUCH PM
Citation: Pm. Mauch, MANAGEMENT OF EARLY-STAGE HODGKINS-DISEASE - THE ROLE OF RADIATION-THERAPY AND OR CHEMOTHERAPY/, Annals of oncology, 7, 1996, pp. 79-84
Authors:
VANOS R
DAWES D
MISLOW KJM
WITSELL A
MAUCH PM
Citation: R. Vanos et al., EFFECTS OF 5-FU ON LONG-TERM REPOPULATING BONE-MARROW STEM-CELLS, Experimental hematology, 24(9), 1996, pp. 77-77
Authors:
VANOS R
MISLOW JMK
MAUCH PM
Citation: R. Vanos et al., THE EFFECT OF G-CSF ON BONE-MARROW STEM-CELL DAMAGE AFTER CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1809-1809
Authors:
MAUCH PM
KALISH LA
MARCUS KC
COLEMAN CN
SHULMAN LN
KRILL E
COME S
SILVER B
CANELLOS GP
TARBELL NJ
Citation: Pm. Mauch et al., 2ND MALIGNANCIES AFTER TREATMENT FOR LAPAROTOMY STAGED IA-IIIB HODGKINS-DISEASE - LONG-TERM ANALYSIS OF RISK-FACTORS AND OUTCOME, Blood, 87(9), 1996, pp. 3625-3632
Authors:
MAUCH PM
CANELLOS GP
SHULMAN LN
SILVER B
TARBELL NJ
COME S
RABIN MS
COLEMAN CN
Citation: Pm. Mauch et al., MANTLE IRRADIATION ALONE FOR SELECTED PATIENTS WITH LAPAROTOMY-STAGEDIA TO IIA HODGKINS-DISEASE - PRELIMINARY-RESULTS OF A PROSPECTIVE TRIAL, Journal of clinical oncology, 13(4), 1995, pp. 947-952
Authors:
VANOS R
DAWES D
WITSELL A
MAUCH PM
Citation: R. Vanos et al., SUCCESSFUL LONG-TERM ENGRAFTMENT AFTER CONDITIONING WITH 5-FU AND KIT-LIGAND, Blood, 86(10), 1995, pp. 426-426
Authors:
MARCUS KC
KALISH LA
COLEMAN CN
SHULMAN LN
ROSENTHAL DS
CANELLOS GP
MAUCH PM
Citation: Kc. Marcus et al., IMPROVED SURVIVAL IN PATIENTS WITH LIMITED STAGE IIIA HODGKINS-DISEASE TREATED WITH COMBINED RADIATION-THERAPY AND CHEMOTHERAPY, Journal of clinical oncology, 12(12), 1994, pp. 2567-2572
Authors:
DOWN JD
MAUCH PM
Citation: Jd. Down et Pm. Mauch, RADIATION SENSITIVITY AND HETEROGENEITY OF HEMATOPOIETIC STEM-CELLS, International journal of radiation oncology, biology, physics, 29(1), 1994, pp. 218-219